BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tilp C, Kapur V, Loging W, Erb KJ. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. Int J Parasitol. 2013;43:319-325. [PMID: 23291462 DOI: 10.1016/j.ijpara.2012.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Siqueira LDP, Fontes DAF, Aguilera CSB, Timóteo TRR, Ângelos MA, Silva LCPBB, de Melo CG, Rolim LA, da Silva RMF, Neto PJR. Schistosomiasis: Drugs used and treatment strategies. Acta Tropica 2017;176:179-87. [DOI: 10.1016/j.actatropica.2017.08.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
2 Lorimer J. Hookworms Make Us Human: The Microbiome, Eco-immunology, and a Probiotic Turn in Western Health Care. Med Anthropol Q 2019;33:60-79. [PMID: 30003599 DOI: 10.1111/maq.12466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
3 Pitrez PM, Gualdi LP, Barbosa GL, Sudbrack S, Ponzi D, Cao RG, Silva AC, Machado DC, Jones MH, Stein RT, Graeff-Teixeira C. Effect of different helminth extracts on the development of asthma in mice: The influence of early-life exposure and the role of IL-10 response. Exp Parasitol 2015;156:95-103. [PMID: 26093162 DOI: 10.1016/j.exppara.2015.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
4 Ditgen D, Anandarajah EM, Meissner KA, Brattig N, Wrenger C, Liebau E. Harnessing the helminth secretome for therapeutic immunomodulators. Biomed Res Int 2014;2014:964350. [PMID: 25133189 DOI: 10.1155/2014/964350] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
5 Correale J. Helminth/Parasite treatment of multiple sclerosis. Curr Treat Options Neurol 2014;16:296. [PMID: 24744099 DOI: 10.1007/s11940-014-0296-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
6 Siles-Lucas M, Morchon R, Simon F, Manzano-Roman R. Exosome-transported microRNAs of helminth origin: new tools for allergic and autoimmune diseases therapy? Parasite Immunol 2015;37:208-14. [PMID: 25712154 DOI: 10.1111/pim.12182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
7 Villeneuve C, Kou HH, Eckermann H, Palkar A, Anderson LG, Mckenney EA, Bollinger RR, Parker W. Evolution of the hygiene hypothesis into biota alteration theory: what are the paradigms and where are the clinical applications? Microbes and Infection 2018;20:147-55. [DOI: 10.1016/j.micinf.2017.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kou HH, Parker W. Intestinal worms eating neuropsychiatric disorders? Apparently so. Brain Res 2018;1693:218-21. [PMID: 29402395 DOI: 10.1016/j.brainres.2018.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Venkatakrishnan A, Sarafian JT, Jirků-Pomajbíková K, Parker W. Socio-medical studies of individuals self-treating with helminths provide insight into clinical trial design for assessing helminth therapy. Parasitol Int 2021;87:102488. [PMID: 34737071 DOI: 10.1016/j.parint.2021.102488] [Reference Citation Analysis]
10 Parker W, Ollerton J. Evolutionary Biology and Anthropology Suggest Biome Reconstitution as a Necessary Approach toward Dealing with Immune Disorders. Evolution, Medicine, and Public Health. 2013;2013:89-103. [PMID: 24481190 DOI: 10.1093/emph/eot008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
11 Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014;69:3-16. [PMID: 24417229 DOI: 10.1111/all.12270] [Cited by in Crossref: 265] [Cited by in F6Publishing: 224] [Article Influence: 29.4] [Reference Citation Analysis]
12 Shepherd C, Navarro S, Wangchuk P, Wilson D, Daly NL, Loukas A. Identifying the immunomodulatory components of helminths. Parasite Immunol 2015;37:293-303. [PMID: 25854639 DOI: 10.1111/pim.12192] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
13 Bhardwaj EK, Else KJ, Rogan MT, Warhurst G. Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice. World J Gastroenterol 2014; 20(7): 1797-1806 [PMID: 24587657 DOI: 10.3748/wjg.v20.i7.1797] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
14 Liu J, Morey R, Wilson J, Parker W. Practices and outcomes of self-treatment with helminths based on physicians' observations. J Helminthol 2017;91:267-77. [DOI: 10.1017/s0022149x16000316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
15 Smyth K, Morton C, Mathew A, Karuturi S, Haley C, Zhang M, Holzknecht ZE, Swanson C, Lin SS, Parker W. Production and Use of Hymenolepis diminuta Cysticercoids as Anti-Inflammatory Therapeutics. J Clin Med 2017;6:E98. [PMID: 29064448 DOI: 10.3390/jcm6100098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lukeš J, Kuchta R, Scholz T, Pomajbíková K. (Self-) infections with parasites: re-interpretations for the present. Trends in Parasitology 2014;30:377-85. [DOI: 10.1016/j.pt.2014.06.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sobotková K, Parker W, Levá J, Růžková J, Lukeš J, Jirků Pomajbíková K. Helminth Therapy - From the Parasite Perspective. Trends Parasitol 2019;35:501-15. [PMID: 31153721 DOI: 10.1016/j.pt.2019.04.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
18 Obieglo K, van Wijck Y, de Kleijn S, Smits HH, Taube C. Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon? Expert Rev Respir Med 2014;8:717-30. [PMID: 25138640 DOI: 10.1586/17476348.2014.949244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
19 Parker W. Not infection with parasitic worms, but rather colonization with therapeutic helminths. Immunology Letters 2017;192:104-5. [DOI: 10.1016/j.imlet.2017.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Wagner A, Schabussova I, Drinic M, Akgün J, Loupal G, Kundi M, Joachim A, Wiedermann U. Oocyst-Derived Extract of Toxoplasma Gondii Serves as Potent Immunomodulator in a Mouse Model of Birch Pollen Allergy. PLoS One 2016;11:e0155081. [PMID: 27149118 DOI: 10.1371/journal.pone.0155081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Parker W, Sarafian JT, Broverman SA, Laman JD. Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity. Evol Med Public Health 2021;9:120-30. [PMID: 33732461 DOI: 10.1093/emph/eoab006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zaccone P, Cooke A. Vaccine against autoimmune disease: can helminths or their products provide a therapy? Curr Opin Immunol 2013;25:418-23. [PMID: 23465465 DOI: 10.1016/j.coi.2013.02.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
23 Fleming JO, Weinstock JV. Clinical trials of helminth therapy in autoimmune diseases: rationale and findings. Parasite Immunol 2015;37:277-92. [PMID: 25600983 DOI: 10.1111/pim.12175] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]